Faiez Zannad

142PUBLICATIONS
559CO-AUTHORS
Respiratory diseasesCardiology (incl. cardiovascular diseases)Cell physiologyCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (142)

|Sep 18, 2026
Neutrophil-to-Lymphocyte Ratio in Patients With Heart Failure: Findings From The EMPEROR Program.

|Sep 16, 2026
Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial.

|Sep 11, 2026
Phenotype-specific prognostic implications of pulse pressure in heart failure.

|Sep 08, 2026
Efficacy of Vericiguat by Background Guideline-Directed Medical Therapy in the VICTOR Trial.

|Aug 31, 2026
Short-term effects of combinations of heart failure therapies on blood pressure, kidney function and serum potassium.

|Aug 18, 2026
Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis.

Pageof 24

Frequent Collaborators

32 joint publications

Carolyn Sp Lam

31 joint publications

Joo Pedro Ferreira

31 joint publications

Milton Packer

30 joint publications

Muthiah Vaduganathan